Mad nucleases
The present disclosure provides new RNA-guided nucleases for making rational, direct edits to nucleic acids in live cells; specifically, the present disclosure provides Type V MAD nucleases (e.g., RNA-guided nucleases or RGNs) with altered PAM preferences and/or altered activity at different temperatures or fidelity, and/or varied nuclease activities; all changes that may increase the versatility of a nucleic acid-guided nuclease for certain editing tasks.
Inscripta, Inc.
C C C C C
C12N C12N C12N C12N C12N
inventional inventional additional additional inventional
Aamir Benjamin Juhan
Mir Mijts Kim